S'abonner

Lipidized dermatofibromas and their relationship to serum lipids - 09/08/11

Doi : 10.1016/j.jaad.2005.11.1036 
Kyle Wagamon, MD a, Stephen C. Somach, MD a, c, Jonathan Bass, MD a, c, Jessica E. Sigel, MD c, Wei Xue, MS b, Mark Schluchter, PhD b, Christine Jaworsky, MD a, c,
a From the Case Western Reserve School of Medicine 
b University Department of Statistics 
c MetroHealth Medical Center 

Correspondence to: Christine Jaworsky, MD, Department of Dermatology, MetroHealth Medical Center, 2500 MetroHealth Blvd, Cleveland, OH 44109.

Cleveland, Ohio

Abstract

Background

Lipidized dermatofibromas represent a rare variant of dermatofibroma that has been regarded as an incidental finding with no particular clinical significance.

Objective

The goal of this study was to investigate the relationship between lipidized dermatofibromas and patient age, anatomic location, and serum total cholesterol.

Methods

A retrospective case control format was used with an experimental group containing patients with biopsy-proven lipidized dermatofibromas and a control group containing patients with nonlipidized dermatofibromas.

Results

Ages in the experimental group ranged from 35 to 75 years with a mean value of 53 years whereas ages in the control group ranged from 27 to 72 years with a mean value of 48 years. A comparison between the mean of the ages between the two groups using the t test method showed no statistically significant difference (P = .09). Lesion location on the body was grouped into 4 sites: leg, thigh, trunk, and upper extremity. Of the 23 patients in the experimental group, 10 had lesions on the legs, 5 had lesions on the thighs, 2 had lesions on the trunk, and 5 had lesions on the upper extremities. Of the 41 patients in the control group, 15 had lesions on the legs, 7 had lesions on the thighs, 9 had lesions on the trunk, and 10 had lesions on the upper extremities. A comparison between the two groups showed no statistically significant difference (P = .60). In all, 16 of the 23 patients in the experimental group and 24 of the 41 patients in the control group were considered to have high cholesterol. A comparison showed no statistically significant difference between the cholesterol levels of the two groups (P = .38).

Limitations

Limitations that we encountered during the study included the relative infrequency of lipidized dermatofibromas, limiting the number of patients in the study. In addition, medication histories and lipid levels on patients were not always available. In addition, we formed a control group from people who had their cholesterol checked often, which may cause them to have a higher average cholesterol than that of the general population.

Conclusions

Our data show that lipidized dermatofibromas do not differ clinically from nonlipidized dermatofibromas in age distribution of patients, tumor location, or underlying serum lipid levels.

Le texte complet de cet article est disponible en PDF.

Plan


 Funding sources: None.
Conflicts of interest: None identified.
Reprints not available from the authors.


© 2006  American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 54 - N° 3

P. 494-498 - mars 2006 Retour au numéro
Article précédent Article précédent
  • Evaluation of the treatment of port-wine stains with the 595-nm long pulsed dye laser: A large prospective study in adult Japanese patients
  • Akihiko Asahina, Takahiro Watanabe, Akiko Kishi, Naoko Hattori, Akira Shirai, Shinji Kagami, Rei Watanabe, Andre Le Pavoux, Takeo Maekawa, Kunihiko Tamaki, Kuniaki Ohara
| Article suivant Article suivant
  • Angiosarcoma after conservation treatment for breast carcinoma: Our experience and a review of the literature
  • János Fodor, Zsolt Orosz, Éva Szabó, Zoltán Sulyok, Csaba Polgár, Zoltán Zaka, Tibor Major

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.